Frontiers in Pharmacology | Neuropharmacology

Review

Published on 23 Apr 2025

Efficacy, safety, and tolerability of soticlestat (TAK-935) as adjunctive therapy in pediatric patients with dravet syndrome and Lennox–Gastaut syndrome: a meta-analysis of 3 randomized controlled trials

in Neuropharmacology

Zhang Lanlan
Jiang Nana
Wang Chengzhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586098

1,353 views

Original Research

Published on 22 Apr 2025

GluN2B influences the progression of status epilepticus by modulating calcium ion homeostasis through its interaction with CaMKIIα

in Neuropharmacology

Lin Zhang
Youshi Meng
Chaoning Liu
Lei Wei
Yuling Lu
Shouhuan Zheng
Donghua Zou
Yuan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550879

1,019 views

Systematic Review

Published on 22 Apr 2025

Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review

in Neuropharmacology

Yu-Hsien Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593191

2,060 views

Review

Published on 16 Apr 2025

Ginsenoside Rg1 in Parkinson’s disease: from basic research to clinical applications

in Neuropharmacology

Qianyan Wang
Lei Wei
Guanghui Chen
Qiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1490480

1,075 views

Original Research

Published on 16 Apr 2025

Significant hindlimb static weight-bearing asymmetry persists for 40-weeks in a longitudinal study in two widely used rat models of surgically induced osteoarthritis knee pain

in Neuropharmacology

A. Kuo
A. Raboczyj
J. R. Nicholson
L. Corradini
M. T. Smith

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560265

594 views
1 citation

Systematic Review

Published on 16 Apr 2025

Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease

in Neuropharmacology

Haoyang Wang
Junying Pan
Mingming Zhang
Zengde Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599048

2,865 views

Review

Published on 14 Apr 2025

Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies

in Neuropharmacology

Cheng Yuan
Fengpei Chang
Hongfu Zhai
Jiayin Du
Danqin Lu
Haoli Ma
Xiaoyan Wu
Ping Gao
Lihua Ni

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559038

1,440 views
1 citation

Editorial

Published on 14 Apr 2025

Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric volume II

in Neuropharmacology

Weijie Xie
Yuan Li
Song Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601881

766 views
1 citation

Systematic Review

Published on 11 Apr 2025

Research trends on neutrophil extracellular traps in ischemic stroke: a scientific metrology study

in Neuropharmacology

Yaji Xu
Xingyu Gong
Yilin Wang
Xinyu Liu
Haomou Pu
Hongjie Jiang
Xiaoping Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1537566

1,913 views

Original Research

Published on 11 Apr 2025

Social hierarchy modulates drug reinforcement and protein phosphorylation in the nucleus accumbens

in Neuropharmacology

Liang Xu
Ruiyi Zhou
Jiafeng Zhong
Yina Huang
Yingjie Zhu
Wei Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1537131

1,214 views

Original Research

Published on 10 Apr 2025

Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample

in Neuropharmacology

Paula Aarseth Tunstad
Tor-Morten Kvam
Malin V. Uthaug
Lowan H. Stewart
Kristoffer A. A. Andersen
Cato Grønnerød

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556299

1,868 views

Original Research

Published on 10 Apr 2025

Tauroursodeoxycholic acid regulates macrophage/monocyte distribution and improves spinal microenvironment to promote nerve regeneration through inhibiting NF-κB signaling pathway in spinal cord injury

in Neuropharmacology

Yonghui Hou
Yage Zhang
Lin Ma
Dan Luo
Wanshun Wang
Shunmei E.
Chengxi Huang
Yu Hou
Shudong Chen
Jiheng Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554945

1,256 views
1 citation

Review

Published on 09 Apr 2025

Role of Achyranthes aspera in neurodegenerative diseases: current evidence and future directions

in Neuropharmacology

Huaiqing Luo
Siwen Wei
Shujun Fu
Li Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511011

1,130 views

Review

Published on 09 Apr 2025

The roles of extracellular vesicles in mental disorders: information carriers, biomarkers, therapeutic agents

in Neuropharmacology

Longkun Wang
Ruixue Liu
Ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591469

879 views

Case Report

Published on 09 Apr 2025

Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumab

in Neuropharmacology

Raquel Piñar-Morales
Raquel Calle-Calle
Maria Carrasco-Garcia
Cristina Davila-Arias
Luisa Maria Villar-Guimerans
Francisco J. Barrero Hernandez

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571699

1,094 views

Original Research

Published on 09 Apr 2025

Interpreting the clinical significance of multiple large-scale mitochondrial DNA deletions (MLSMD) in skeletal muscle tissue in the diagnostic evaluation of primary mitochondrial disease

in Neuropharmacology

Jing Wang
James T. Peterson
Joaquim Diego D. Santos
Ada J. S. Chan
Maria Alejandra Diaz-Miranda
Imon Rahaman
Jean Flickinger
Amy Goldstein
Emily Bogush
Elizabeth M. McCormick

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507493

1,518 views